Franzen Achim M, Günzel Thomas, Lieder Anja
Klinik für HNO-Krankheiten und Plastische Operationen, Ruppiner Kliniken, Brandenburg Medical School Theodor-Fontane, Neuruppin, Germany.
Klinik für HNO-Krankheiten, Borromäus-Hospital, Leer, Germany.
Auris Nasus Larynx. 2016 Apr;43(2):187-91. doi: 10.1016/j.anl.2015.09.010. Epub 2015 Oct 29.
Metastatic disease is common among parotid malignancies. The majority of primary tumours are located in the head and neck, but primary tumours below the clavicle must also be considered, especially in histological types not usually found in primary parotid or skin tumours.
We performed 644 consecutive parotidectomies between 1980 and 2012. Benign tumours were found in 555 patients (86%) and malignant tumours in 89 patients (14%).
Of 89 malignant tumours, 39 were metastases (44%). In 5 cases, the primary tumour was located below the clavicle (6% of malignant tumours). A carcinoma of the bronchus was subsequently diagnosed in three patients: one patient had breast carcinoma and one renal cell carcinoma.
The majority of metastases in the parotid gland arise from primary tumours of the head and neck. In 10-20% of metastases, the primary tumour arises below the clavicle. Parotid metastases can be the first clinical manifestation of a malignant tumour, and can also occur years after curative intent treatment. Histopathology and immunohistochemistry will offer clues to a possible metastatic process and to primary tumour location. Parotidectomy with complete excision of the tumour can be a curative measure or form an essential part of symptom control and should be considered in all but the most moribund patients.
转移性疾病在腮腺恶性肿瘤中很常见。大多数原发性肿瘤位于头颈部,但锁骨以下的原发性肿瘤也必须考虑在内,尤其是在原发性腮腺或皮肤肿瘤中不常见的组织学类型。
我们在1980年至2012年间连续进行了644例腮腺切除术。555例患者(86%)发现良性肿瘤,89例患者(14%)发现恶性肿瘤。
89例恶性肿瘤中,39例为转移瘤(44%)。5例患者的原发性肿瘤位于锁骨以下(占恶性肿瘤的6%)。随后3例患者被诊断为支气管癌:1例患者为乳腺癌,1例为肾细胞癌。
腮腺转移瘤大多起源于头颈部原发性肿瘤。10% - 20%的转移瘤,其原发性肿瘤起源于锁骨以下。腮腺转移瘤可能是恶性肿瘤的首发临床表现,也可在根治性治疗多年后发生。组织病理学和免疫组化将为可能的转移过程及原发性肿瘤位置提供线索。完整切除肿瘤的腮腺切除术可以是一种治愈性措施,或构成症状控制的重要部分,除病情最严重的患者外,所有患者均应考虑施行。